Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
William G. Wierda(The University of Texas MD Anderson Cancer Center), Hema Sundar, Tanya Siddiqi(City Of Hope National Medical Center), Brian T. Hill(Cleveland Clinic), Claudio A. Mosse(Breast Cancer Research Foundation), Asher Chanan‐Khan(WinnMed), Randall S. Davis(University of Colorado Cancer Center), Steven Coutré(Georgetown University), Jennifer R. Brown(Dana-Farber Cancer Institute), Suchitra Sundaram(Roswell Park Comprehensive Cancer Center), Mary Dwyer(Peter MacCallum Cancer Centre), Deborah M. Stephens(University of North Carolina at Chapel Hill), Thomas J. Kipps(Moores Cancer Center), Megan S. Lim(University of Pennsylvania), Danielle M. Brander(Duke University), Christopher D.�M. Fletcher(Harvard University), Mazyar Shadman(University of Washington), Lawrence D. Kaplan(UCSF Helen Diller Family Comprehensive Cancer Center), Brad S. Kahl(UW Health University Hospital), Nadia Khan(Fox Chase Cancer Center), Shuo Ma(Nantong University), Julio C. Chávez(Moffitt Cancer Center), Nina Wagner(Sidney Kimmel Comprehensive Cancer Center), Anthony Mato(Memorial Sloan Kettering Cancer Center), Greg Bociek(Susan Thompson Buffett Foundation), Sami N. Malek(University of Michigan), Manali Kamdar(University of Colorado Cancer Center), S Bilgrami(Yale Cancer Center), John C. Byrd(The Ohio State University)
Cited by 143
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k